Alliance Pharma (APH)
11/01/2018 - 07:57 StockMarketWire
Hardman Research has issued a report on Alliance Pharma. It says: 'Alliance Pharma is continuing with its buy-and-build ...
11/01/2018 - 07:15 RNS
RNS Number: 5498B Alliance Pharma PLC 11 January 2018 Hardman Research: Acquisitions to boost growth prospects Acquisitions to boost growth prospects - Alliance Pharma is continuing with its buy-and-build strategy, having evolved through 35 acquisitions over a period of 20 years into a profitable, cash generative, specialty pharma business. The company has a...
02/01/2018 - 14:00 RNS
RNS Number: 7423A Alliance Pharma PLC 02 January 2018 ALLIANCE PHARMA PLC ("Alliance" or the "Company") Total Voting Rights Alliance Pharma plc (AIM: APH), the specialty pharmaceutical company, makes the following notification in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. As at 29 December ...
02/01/2018 - 07:00 RNS
RNS Number: 6116A Alliance Pharma PLC 02 January 2018 ALLIANCE PHARMA PLC ("Alliance" or the "Group") Block Listing Six Monthly Return Name of applicant: ALLIANCE PHARMA PLC Names of schemes: a) The Alliance Pharma plc Approved Share Option Plan 2005 b) The Alliance Pharma plc Share Option Plan 2006 c) The Alliance Pharma plc Com...
Join interactive investor
- £22.50 fixed quarterly charge includes £22.50 in trading credits
- £10 per trade or £6 for frequent traders
- No % platform fees
- £1 per trade for regular investment or dividend reinvestment